PennyStocksUpdate.biz is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
New York, NY -- (SBWIRE) -- 01/08/2013 -- Perion Network Ltd. (NASDAQ:PERI) announced Tuesday morning that its full year 2013 revenue is expected to exceed $110 million, with non-GAAP EPS of at least $1.61.The company also expects to report fourth quarter revenues of $21 million and full year 2012 non-GAAP revenues of $61 million.Perion Network gapped open sharply higher Tuesday and is now up 2.33 at $11.78 on the highest volume of the year. The stock has surged to a new high for the year.
Click here to receive FREE breaking news email alerts for Perion Network Ltd.
Cell Therapeutics (NASDAQ:CTIC) is +0.34 - +26.15% from the previous close of $1.30. It traded between $1.38 - 1.71 with total traded volume of 6001965 shares. Keep a close eye on CTIC, as the stock has been showing unusual moves over the past weeks. At Current market price, CTIC has recovered +43.86% from its 52-week Low of 1.14 and has Pulled back -80.12% from its 52-week high of 8.25.
Should Investors Buy CTIC Now? Free Sign Up Here For CTIC Analyst Report
Star Scientific Inc (NASDAQ:STSI) slipped 2.84% and closed at $2.74 on a traded volume of 1.27 million shares. The Company announced successful results from the Company’s ASAP Human Thyroid Study that analyzes the impact of anatabine dietary supplementation on thyroid health. The study is a three-month, five-visit, double-blind, placebo-controlled study of the impact of anatabine dietary supplementation in humans with autoimmune disease of the thyroid. The study was conducted at nine sites and builds upon previous epidemiological and animal experimental studies.
Is STSI Showing Any Sign of Buy At The Current Market Price? Get Our Free Trend Analysis Here
Newcastle Investment Corp. (NYSE:NCT) traded with an upsurge of 6.79% and closed at $9.60 after gaining total volume of 14,230,500 shares. Its opening price was $9.44. Newcastle Investment Company’s earnings per share is $2.71 while its beta value stands at 3.30 times. Newcastle Investment Corp. (NYSE: NCT) unveiled its plans of public an offering of 40,000,000 shares of its common stock. Along with this offering, the Company proposes an offer of 30 days to its underwriters to purchase up to 6,000,000 additional shares of common stock.
Is NCT Will Continue Higher? Find Out Where NCT Is Headed Next With A FREE TREND ANALYSIS REPORT
Neither PennyStocksUpdate.biz nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by PennyStocksUpdate.biz, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation.PennyStocksUpdate.biz makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through PennyStocksUpdate.biz. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned here in..
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)